Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 269

1.

Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection.

Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Ogura Y, Izumi N, Marumo F, Sato C.

N Engl J Med. 1996 Jan 11;334(2):77-81.

2.
3.
5.

Analysis of genotypes and amino acid residues 2209 to 2248 of the NS5A region of hepatitis C virus in relation to the response to interferon-beta therapy.

Kurosaki M, Enomoto N, Murakami T, Sakuma I, Asahina Y, Yamamoto C, Ikeda T, Tozuka S, Izumi N, Marumo F, Sato C.

Hepatology. 1997 Mar;25(3):750-3.

PMID:
9049230
6.
7.

The mutations in ISDR of NS5A gene are not associated with response to interferon treatment in Turkish patients with chronic hepatitis C virus genotype 1b infection.

Aslan N, Bozdayi AM, Cetinkaya H, Sarioğlu M, Türkay C, Bozkaya H, Karayalçin S, Yurtaydin C, Uzunalimoğlu O.

Turk J Gastroenterol. 2004 Mar;15(1):21-6.

8.

Mutations in nonstructural protein 5A gene and response to interferon in hepatitis C virus genotype 2 infection.

Murakami T, Enomoto N, Kurosaki M, Izumi N, Marumo F, Sato C.

Hepatology. 1999 Oct;30(4):1045-53.

PMID:
10498658
9.

Mutations in the nonstructural 5A region of hepatitis C virus and response of chronic hepatitis C to interferon alfa.

Squadrito G, Leone F, Sartori M, Nalpas B, Berthelot P, Raimondo G, Pol S, Bréchot C.

Gastroenterology. 1997 Aug;113(2):567-72.

PMID:
9247477
10.

NS5A mutations predict biochemical but not virological response to interferon-alpha treatment of sporadic hepatitis C virus infection in European patients.

Stratidaki I, Skoulika E, Kelefiotis D, Matrella E, Alexandrakis G, Economou A, Kouroumalis E.

J Viral Hepat. 2001 Jul;8(4):243-8.

PMID:
11454174
11.

Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection.

Chayama K, Tsubota A, Kobayashi M, Okamoto K, Hashimoto M, Miyano Y, Koike H, Kobayashi M, Koida I, Arase Y, Saitoh S, Suzuki Y, Murashima N, Ikeda K, Kumada H.

Hepatology. 1997 Mar;25(3):745-9.

PMID:
9049229
12.

Sequences in the NS5A protein of hepatitis C virus and the serum alanine aminotransferase response to interferon therapy in Japanese patients.

Nagayama K, Enomoto N, Izumi N, Kurosaki M, Miyasaka Y, Watanabe H, Itakura J, Chen CH, Tazawa J, Hoshino Y, Ikeda T, Marumo F, Sato C.

Gut. 2001 Jun;48(6):830-5.

13.

Nucleotide sequence variations in the internal ribosome entry site of hepatitis C virus-1b: no association with efficacy of interferon therapy or serum HCV-RNA levels.

Yamamoto C, Enomoto N, Kurosaki M, Yu SH, Tazawa J, Izumi N, Marumo F, Sato C.

Hepatology. 1997 Dec;26(6):1616-20.

PMID:
9398006
14.

Interferon sensitivity-determining region of nonstructural region 5A of hepatitis C virus genotype 1b correlates with serum alanine aminotransferase levels in chronic infection.

Yoshioka K, Ito H, Watanabe K, Yano M, Ishigami M, Mizutani T, Sasaki Y, Goto H.

J Viral Hepat. 2005 Mar;12(2):139-45.

PMID:
15720528
15.

The prognostic relevance of the nonstructural 5A gene interferon sensitivity determining region is different in infections with genotype 1b and 3a isolates of hepatitis C virus.

Sáiz JC, López-Labrador FX, Ampurdanés S, Dopazo J, Forns X, Sánchez-Tapias JM, Rodés J.

J Infect Dis. 1998 Apr;177(4):839-47.

16.

Is investigation of hepatitis C virus NS5A gene heterogeneity a tool for predicting long-lasting response to interferon therapy in patients with HCV-1b chronic hepatitis?

Squadrito G, Raffa G, Restuccia T, Pollicino T, Brancatelli S, Raimondo G.

J Viral Hepat. 2002 Sep;9(5):360-9.

PMID:
12225331
17.

Integrity of the NS5A (amino acid 2209 to 2248) region in hepatitis C virus 1b patients non-responsive to interferon therapy.

Halfon P, Halimi G, Bourlière M, Ouzan D, Durant J, Khiri H, Mercier L, Gerolami V, Cartouzou G.

Liver. 2000 Oct;20(5):381-6.

PMID:
11092256
18.

Efficacy and changes of the nonstructural 5A GENE by prolonged interferon therapy for patients with hepatitis C virus genotype 1b and a high level of serum HCV-RNA.

Arase Y, Ikeda K, Chayama K, Murashima N, Tsubota A, Suzuki Y, Saitoh S, Kobayashi M, Kobayashi M, Kobayashi M, Kumada H.

Intern Med. 1999 Jun;38(6):461-6.

19.
20.

[Interferon resistance and ISDR (interferon sensitivity determining region)].

Amemiya F, Maekawa S, Enomoto N.

Nihon Rinsho. 2006 Jul;64(7):1249-53. Review. Japanese.

PMID:
16838640
Items per page

Supplemental Content

Support Center